Superworth

InnovAge price to free cash flow INNV

Market value divided by free cash flow over the last twelve months, since 2022.

Today, Nov 2, 2026
24.1×
5-year median
31.2×
Against its 5-year history
29th
percentile: 0 is its lowest day, 100 its highest
5-year range
18.2× to 127×
Peer median
15.2×

InnovAge's price to free cash flow is 24.1× as of Nov 2, 2026.

That is below its 5-year median of 31.2×, lower than on 71% of days in the last 5 years.

Over that time it ranged from 18.2× in Nov 2025 to 127× in Apr 2022.

The median for 10 hospital and care facility stocks of a similar size is 15.2×.

Price to free cash flow over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far24.1×19.5×38.2×
202520.8×18.2×37.7×
2024n/m a value too high to mean anything
2023n/m a value too high to mean anything
202251.7×50.0×127×

Against its peers

Companies in Medical - Care Facilities nearest InnovAge's size, closest first, today.

CompanyPrice to free cash flow
INNVInnovAge24.1×
USPHU S Physical Therapy19.8×
OMDAOmada Health48.1×
PNTGPennant40.8×
ARDTArdent Health5.4×
HCSGHealthcare Services16.3×
PGNYProgyny12.6×
ADUSAddus HomeCare15.2×
MDPediatrix Medical11.4×
SBCSBC Medical8.8×
PRVAPrivia Healthn/m
Peer median15.2×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on InnovAge

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.